%0 Journal Article
%T Long-Term follow up after intra-Uterine transfusionS; the LOTUS study
%A Esther P Verduin
%A Irene TM Lindenburg
%A Vivianne EHJ Smits-Wintjens
%A Jeanine MM van Klink
%A Henk Schonewille
%A Inge L van Kamp
%A Dick Oepkes
%A Frans J Walther
%A Humphrey HH Kanhai
%A Ilias IN Doxiadis
%A Enrico Lopriore
%A Anneke Brand
%J BMC Pregnancy and Childbirth
%D 2010
%I BioMed Central
%R 10.1186/1471-2393-10-77
%X We set up a large long-term observational follow-up study (LOTUS study), in cooperation with the Sanquin Blood Supply Foundation and the LUMC departments of Obstetrics, Neonatology and ImmunoHematology & Bloodtransfusion.The first part of this study addresses several putative mechanisms associated with blood group alloimmunization in these mothers. The second part of this study determines the incidence of long-term neurodevelopment impairment (NDI) and associated risk factors in children treated with IUT. All women and their life offspring who have been treated with IUT for HDFN in the LUMC from 1987-2008 are invited to participate and after consent, blood or saliva samples are taken. RBC and HLA antigen profile and antibodies are determined by serologic or molecular techniques. Microchimerism populations are tested by real time polymerase chain reaction (RT PCR).All children are tested for their neurological, cognitive and psychosocial development using standardised tests and questionnaires. The primary outcome is neurodevelopmental impairment (NDI), a composite outcome defined as any of the following: cerebral palsy, cognitive or psychomotor development < 2 standard deviation, bilateral blindness and/or bilateral deafness.The LOTUS study includes the largest cohort of IUT patients ever studied and is the first to investigate post-IUT long-term effects in both mother and child. The results may lead to a change in transfusion policy, in particular future avoidance of certain incompatibilities. Additionally the LOTUS study will provide clinicians and parents better insights in the long-term neurodevelopmental outcome in children with HDFN treated with IUTs, and may improve the quality of antenatal counselling and long-term guidance.Alloimmunization is a major transfusion problem and deliberate transfusions may induce multiple red cell, platelet and HLA specific antibodies. Some transfusion recipients seem more susceptible for alloimmunization, but with respect to red
%U http://www.biomedcentral.com/1471-2393/10/77